BMS-986020

DB14948InvestigationalSmall molecule

BMS-986020 is under investigation in clinical trial NCT02017730 (To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers).

Mechanism: Pharmacologically active on Lysophosphatidic acid receptor 1
Curator reviewed
Formula / weight: C₂₉H₂₆N₂O₅ · 482.536 g/mol (avg)
Code names: AM-152 · BMS-986020

Resolves to

Compound

UNII38CTP01B4LCAS1257213-50-5ChEMBLCHEMBL4297270

Structure

InChIKeyGQBRZBHEPUQRPL-LJQANCHMSA-NSMILESC[C@@H](OC(=O)NC1=C(ON=C1C)C1=CC=C(C=C1)C1=CC=C(C=C1)C1(CC1)C(O)=O)C1=CC=CC=C1

Targets

Q92633LPAR1

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-986020, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account